Rebecca A. Byam - 11 Sep 2023 Form 4 Insider Report for HCW Biologics Inc. (HCWB)

Role
Chief Financial Officer
Signature
/s/ Nicole Valdivieso, as Attorney-in-Fact for Rebecca A. Byam
Issuer symbol
HCWB
Transactions as of
11 Sep 2023
Net transactions value
+$20,715
Form type
4
Filing time
13 Sep 2023, 17:33:22 UTC
Previous filing
08 Sep 2023
Next filing
15 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCWB Common Stock Purchase $10,273 +5,000 +0.89% $2.05 563,946 11 Sep 2023 Direct F1
transaction HCWB Common Stock Purchase $10,442 +5,000 +0.89% $2.09 568,946 12 Sep 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The range of prices for the shares of Common Stock is from $2.01 to $2.09. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price.
F2 The range of prices for the shares of Common Stock is from $2.07 to $2.10. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price.